[Skip to Content]
[Skip to Content Landing]
Views 588
Citations 0
Comment & Response
January 15, 2014

Formulation of Treatment Recommendations for Statins—Reply

Author Affiliations
  • 1Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Boston, Massachusetts
  • 2Emory Clinical Cardiovascular Research Institute, Atlanta, Georgia
JAMA. 2014;311(3):306. doi:10.1001/jama.2013.284481

In Reply We concur with Dr O’Sullivan and Ms Brown that only those trials that use actual clinical outcomes should inform practice. For the great majority of trials that we cited, the common end point was inclusive of myocardial infarction, stroke, revascularization for unstable angina, or vascular death. How one chooses to weight those outcomes is a matter of opinion, and thus we differ somewhat from O’Sullivan and Brown in that we believe a reduction in the need for angioplasty or bypass surgery is a relevant benefit for patients.

First Page Preview View Large
First page PDF preview
First page PDF preview